Clinical trial Recruiting at 1 site Observational

Genetic analysis of Craniometaphyseal Dysplasia

Official title: Identification of Mutations That Lead to Craniometaphyseal Dysplasia in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms

Run by UConn Health · NCT01630460 · Data updated 2026-11-12

This study is trying to find out the genetic reasons behind Craniometaphyseal Dysplasia by looking at blood and tissue samples from patients and their family members to help slow down the extra bone growth it causes.

Quick facts

Study typeObservational
SexAll
Enrollment600 (estimated)
SponsorUConn Health
Academic / other
Locations1 site (Farmington, Connecticut)
StatusRecruiting
StartedApril 2009
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedApril 17, 2026
Trial IDNCT01630460 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with Craniometaphyseal Dysplasia and unaffected family members participating in the study.

Probably not a fit

Patients without Craniometaphyseal Dysplasia or those not related to affected individuals may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify the genetic causes of Craniometaphyseal Dysplasia (CMD), a rare bone disorder characterized by excessive bone deposition in the cranial and long bones. Researchers will analyze blood and tissue samples from affected patients to understand the underlying mechanisms of the disorder. The long-term goal is to discover ways to slow down the abnormal bone growth associated with CMD. The study will include both affected individuals and unaffected family members for comparison.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and management of Craniometaphyseal Dysplasia, potentially slowing disease progression.

How similar studies have gone: While CMD is a rare condition, genetic studies of similar bone disorders have shown promise in identifying underlying causes and potential treatments.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* CMD; unaffected individuals only if part of a participating CMD family

Exclusion Criteria:

* No CMD; unaffected individuals only as part of a participating CMD family

Where it's running

  • University of Connecticut Health Center
    Farmington, Connecticut, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.